Why coffee reduces heart disease risks

Abstract

Get full access to this article

View all access options for this article.

References

Shi

Wan

Zhou

et al.

Why various wines reduce the risks of heart diseases. Eur J Prev Cardiol 2017; 24: 1646–1647.

Shi

Wan

Wang

et al.

Mechanism underlying gender difference in heart disease risks and corresponding preventive measures. Eur J Prev Cardiol 2017; 24: 1807–1808.

Wan

Zou

Shi

et al.

How to avoid sudden cardiac death. Eur J Prev Cardiol 2017; 24: 1790–1790.

Zhou

Shi

Wan

et al.

Why the Mediterranean diet lowers the risk of heart disease. Eur J Prev Cardiol 2017; 24: 1788–1789.

Feng

et al.

Calcium supplement is a major concern for patients with cardiovascular diseases. Eur J Prev Cardiol. 2018; 25: 641.

Shi

Wan

Wang

et al.

Can acetic acid substitute ethanol for the reduction of cardiovascular disease risks?

Eur J Prev Cardiol 2017; 24: 1889–1890.

Andersen

Jacobs

Jr Carlsen

et al.

Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr 2006; 83: 1039–1046.

Tang

Zhou

et al.

Hydrogen donors and acceptors and basic amino acids jointly contribute to carcinogenesis. Med Hypotheses 2017; 98: 42–44.

Zhang

Tang

Shi

et al.

Appearance of somatic mutations can be subjected to the influences of inherited factors. Science 2017. http://science.sciencemag.org/content/355/6331/1330/tab-e-letters (accessed 2 February 2017).

10.

Ong

Hwang

Cuellar-Partida

et al.

Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol. Epub ahead of print 25 November 2017. DOI: 10.1093/ije/dyx236.

11.

Shimazu

Tsubono

Kuriyama

et al.

Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005; 116: 150–154.

12.

Klug

Bågeman

Ingvar

et al.

Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels. Mol Genet Metab 2006; 89: 381–389.